InforLorV4, PubMed, Corpus, bibRecord, 000064

Regional differences in heart failure with preserved ejection fraction trials: when nephrology meets cardiology but east does not meet west.

Identifieur interne : 000064 ( PubMed/Corpus ); précédent : 000063; suivant : 000065

Regional differences in heart failure with preserved ejection fraction trials: when nephrology meets cardiology but east does not meet west.

Auteurs : Patrick Rossignol ; Faiez Zannad

Source :

Circulation [ 1524-4539 ] ; 2015.

RBID : pubmed:25406307

English descriptors

KwdEn :
- Benzimidazoles (therapeutic use), Biphenyl Compounds (therapeutic use), Female, Fluorobenzenes (therapeutic use), Geography, Heart Failure (drug therapy), Heart Failure (physiopathology), Humans, Internationality, Male, Mineralocorticoid Receptor Antagonists (therapeutic use), Patients, Pyrimidines (therapeutic use), Rosuvastatin Calcium, Spironolactone (therapeutic use), Stroke Volume (physiology), Sulfonamides (therapeutic use), Tetrazoles (therapeutic use).
MESH :
- chemical , therapeutic use : Benzimidazoles, Biphenyl Compounds, Fluorobenzenes, Mineralocorticoid Receptor Antagonists, Pyrimidines, Spironolactone, Sulfonamides, Tetrazoles.
- drug therapy : Heart Failure.
- physiology : Stroke Volume.
- physiopathology : Heart Failure.
- Female, Geography, Humans, Internationality, Male, Patients, Rosuvastatin Calcium.

DOI: 10.1161/CIRCULATIONAHA.114.013637
PubMed: 25406307

Links to Exploration step

pubmed:25406307

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Regional differences in heart failure with preserved ejection fraction trials: when nephrology meets cardiology but east does not meet west.</title>
<author><name sortKey="Rossignol, Patrick" sort="Rossignol, Patrick" uniqKey="Rossignol P" first="Patrick" last="Rossignol">Patrick Rossignol</name>
<affiliation><nlm:affiliation>From Inserm, Centre d'Investigations Cliniques-Plurithématique 1433 and Inserm U1116, Nancy, France (P.R., F.Z.); CHU Nancy, Département de Cardiologie, Institut Lorrain du Cœur et des Vaisseaux, Vandoeuvre lès Nancy, Nancy, France (P.R., F.Z.); Université de Lorraine, Nancy, France (P.R., F.Z.); and INI-CRCT (Cardiovascular and Renal Clinical Trialists), French-Clinical Research Infrastructure Network (F-CRIN), Nancy, France (P.R., F.Z.). p.rossignol@chu-nancy.fr.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Zannad, Faiez" sort="Zannad, Faiez" uniqKey="Zannad F" first="Faiez" last="Zannad">Faiez Zannad</name>
<affiliation><nlm:affiliation>From Inserm, Centre d'Investigations Cliniques-Plurithématique 1433 and Inserm U1116, Nancy, France (P.R., F.Z.); CHU Nancy, Département de Cardiologie, Institut Lorrain du Cœur et des Vaisseaux, Vandoeuvre lès Nancy, Nancy, France (P.R., F.Z.); Université de Lorraine, Nancy, France (P.R., F.Z.); and INI-CRCT (Cardiovascular and Renal Clinical Trialists), French-Clinical Research Infrastructure Network (F-CRIN), Nancy, France (P.R., F.Z.).</nlm:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2015">2015</date>
<idno type="RBID">pubmed:25406307</idno>
<idno type="pmid">25406307</idno>
<idno type="doi">10.1161/CIRCULATIONAHA.114.013637</idno>
<idno type="wicri:Area/PubMed/Corpus">000064</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000064</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Regional differences in heart failure with preserved ejection fraction trials: when nephrology meets cardiology but east does not meet west.</title>
<author><name sortKey="Rossignol, Patrick" sort="Rossignol, Patrick" uniqKey="Rossignol P" first="Patrick" last="Rossignol">Patrick Rossignol</name>
<affiliation><nlm:affiliation>From Inserm, Centre d'Investigations Cliniques-Plurithématique 1433 and Inserm U1116, Nancy, France (P.R., F.Z.); CHU Nancy, Département de Cardiologie, Institut Lorrain du Cœur et des Vaisseaux, Vandoeuvre lès Nancy, Nancy, France (P.R., F.Z.); Université de Lorraine, Nancy, France (P.R., F.Z.); and INI-CRCT (Cardiovascular and Renal Clinical Trialists), French-Clinical Research Infrastructure Network (F-CRIN), Nancy, France (P.R., F.Z.). p.rossignol@chu-nancy.fr.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Zannad, Faiez" sort="Zannad, Faiez" uniqKey="Zannad F" first="Faiez" last="Zannad">Faiez Zannad</name>
<affiliation><nlm:affiliation>From Inserm, Centre d'Investigations Cliniques-Plurithématique 1433 and Inserm U1116, Nancy, France (P.R., F.Z.); CHU Nancy, Département de Cardiologie, Institut Lorrain du Cœur et des Vaisseaux, Vandoeuvre lès Nancy, Nancy, France (P.R., F.Z.); Université de Lorraine, Nancy, France (P.R., F.Z.); and INI-CRCT (Cardiovascular and Renal Clinical Trialists), French-Clinical Research Infrastructure Network (F-CRIN), Nancy, France (P.R., F.Z.).</nlm:affiliation>
</affiliation>
</author>
</analytic>
<series><title level="j">Circulation</title>
<idno type="eISSN">1524-4539</idno>
<imprint><date when="2015" type="published">2015</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Benzimidazoles (therapeutic use)</term>
<term>Biphenyl Compounds (therapeutic use)</term>
<term>Female</term>
<term>Fluorobenzenes (therapeutic use)</term>
<term>Geography</term>
<term>Heart Failure (drug therapy)</term>
<term>Heart Failure (physiopathology)</term>
<term>Humans</term>
<term>Internationality</term>
<term>Male</term>
<term>Mineralocorticoid Receptor Antagonists (therapeutic use)</term>
<term>Patients</term>
<term>Pyrimidines (therapeutic use)</term>
<term>Rosuvastatin Calcium</term>
<term>Spironolactone (therapeutic use)</term>
<term>Stroke Volume (physiology)</term>
<term>Sulfonamides (therapeutic use)</term>
<term>Tetrazoles (therapeutic use)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Benzimidazoles</term>
<term>Biphenyl Compounds</term>
<term>Fluorobenzenes</term>
<term>Mineralocorticoid Receptor Antagonists</term>
<term>Pyrimidines</term>
<term>Spironolactone</term>
<term>Sulfonamides</term>
<term>Tetrazoles</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Heart Failure</term>
</keywords>
<keywords scheme="MESH" qualifier="physiology" xml:lang="en"><term>Stroke Volume</term>
</keywords>
<keywords scheme="MESH" qualifier="physiopathology" xml:lang="en"><term>Heart Failure</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Female</term>
<term>Geography</term>
<term>Humans</term>
<term>Internationality</term>
<term>Male</term>
<term>Patients</term>
<term>Rosuvastatin Calcium</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<pubmed><MedlineCitation Owner="NLM" Status="MEDLINE"><PMID Version="1">25406307</PMID>
<DateCreated><Year>2015</Year>
<Month>01</Month>
<Day>06</Day>
</DateCreated>
<DateCompleted><Year>2015</Year>
<Month>03</Month>
<Day>26</Day>
</DateCompleted>
<DateRevised><Year>2015</Year>
<Month>11</Month>
<Day>19</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1524-4539</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>131</Volume>
<Issue>1</Issue>
<PubDate><Year>2015</Year>
<Month>Jan</Month>
<Day>6</Day>
</PubDate>
</JournalIssue>
<Title>Circulation</Title>
<ISOAbbreviation>Circulation</ISOAbbreviation>
</Journal>
<ArticleTitle>Regional differences in heart failure with preserved ejection fraction trials: when nephrology meets cardiology but east does not meet west.</ArticleTitle>
<Pagination><MedlinePgn>7-10</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1161/CIRCULATIONAHA.114.013637</ELocationID>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rossignol</LastName>
<ForeName>Patrick</ForeName>
<Initials>P</Initials>
<AffiliationInfo><Affiliation>From Inserm, Centre d'Investigations Cliniques-Plurithématique 1433 and Inserm U1116, Nancy, France (P.R., F.Z.); CHU Nancy, Département de Cardiologie, Institut Lorrain du Cœur et des Vaisseaux, Vandoeuvre lès Nancy, Nancy, France (P.R., F.Z.); Université de Lorraine, Nancy, France (P.R., F.Z.); and INI-CRCT (Cardiovascular and Renal Clinical Trialists), French-Clinical Research Infrastructure Network (F-CRIN), Nancy, France (P.R., F.Z.). p.rossignol@chu-nancy.fr.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Zannad</LastName>
<ForeName>Faiez</ForeName>
<Initials>F</Initials>
<AffiliationInfo><Affiliation>From Inserm, Centre d'Investigations Cliniques-Plurithématique 1433 and Inserm U1116, Nancy, France (P.R., F.Z.); CHU Nancy, Département de Cardiologie, Institut Lorrain du Cœur et des Vaisseaux, Vandoeuvre lès Nancy, Nancy, France (P.R., F.Z.); Université de Lorraine, Nancy, France (P.R., F.Z.); and INI-CRCT (Cardiovascular and Renal Clinical Trialists), French-Clinical Research Infrastructure Network (F-CRIN), Nancy, France (P.R., F.Z.).</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016420">Comment</PublicationType>
<PublicationType UI="D016421">Editorial</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2014</Year>
<Month>11</Month>
<Day>18</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>Circulation</MedlineTA>
<NlmUniqueID>0147763</NlmUniqueID>
<ISSNLinking>0009-7322</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D001562">Benzimidazoles</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D001713">Biphenyl Compounds</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D005464">Fluorobenzenes</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000451">Mineralocorticoid Receptor Antagonists</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D011743">Pyrimidines</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D013449">Sulfonamides</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D013777">Tetrazoles</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>138402-11-6</RegistryNumber>
<NameOfSubstance UI="C081309">irbesartan</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>27O7W4T232</RegistryNumber>
<NameOfSubstance UI="D013148">Spironolactone</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>83MVU38M7Q</RegistryNumber>
<NameOfSubstance UI="D000068718">Rosuvastatin Calcium</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>S8Q36MD2XX</RegistryNumber>
<NameOfSubstance UI="C081643">candesartan</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList><CommentsCorrections RefType="CommentOn"><RefSource>Circulation. 2015 Jan 6;131(1):34-42</RefSource>
<PMID Version="1">25406305</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="CommentOn"><RefSource>Circulation. 2015 Jan 6;131(1):43-53</RefSource>
<PMID Version="1">25406306</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList><MeshHeading><DescriptorName MajorTopicYN="N" UI="D001562">Benzimidazoles</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D001713">Biphenyl Compounds</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D005464">Fluorobenzenes</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="Y" UI="D005843">Geography</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D006333">Heart Failure</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000188">drug therapy</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000503">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="Y" UI="D038622">Internationality</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D000451">Mineralocorticoid Receptor Antagonists</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="Y" UI="D010361">Patients</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D011743">Pyrimidines</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D000068718">Rosuvastatin Calcium</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D013148">Spironolactone</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D013318">Stroke Volume</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D013449">Sulfonamides</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D013777">Tetrazoles</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Editorials</Keyword>
<Keyword MajorTopicYN="N">aldosterone</Keyword>
<Keyword MajorTopicYN="N">clinical trials as topic</Keyword>
<Keyword MajorTopicYN="N">heart failure</Keyword>
<Keyword MajorTopicYN="N">kidney function</Keyword>
<Keyword MajorTopicYN="N">mineralocorticoids</Keyword>
<Keyword MajorTopicYN="N">ventricular function, left</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="aheadofprint"><Year>2014</Year>
<Month>11</Month>
<Day>18</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2014</Year>
<Month>11</Month>
<Day>20</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2014</Year>
<Month>11</Month>
<Day>20</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2015</Year>
<Month>3</Month>
<Day>27</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">25406307</ArticleId>
<ArticleId IdType="pii">CIRCULATIONAHA.114.013637</ArticleId>
<ArticleId IdType="doi">10.1161/CIRCULATIONAHA.114.013637</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Lorraine/explor/InforLorV4/Data/PubMed/Corpus

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000064 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 000064 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Lorraine
   |area=    InforLorV4
   |flux=    PubMed
   |étape=   Corpus
   |type=    RBID
   |clé=     pubmed:25406307
   |texte=   Regional differences in heart failure with preserved ejection fraction trials: when nephrology meets cardiology but east does not meet west.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i   -Sk "pubmed:25406307" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd   \
       | NlmPubMed2Wicri -a InforLorV4

This area was generated with Dilib version V0.6.33.
Data generation: Mon Jun 10 21:56:28 2019. Site generation: Fri Feb 25 15:29:27 2022

	Serveur d'exploration sur la recherche en informatique en Lorraine
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration sur la recherche en informatique en Lorraine

Regional differences in heart failure with preserved ejection fraction trials: when nephrology meets cardiology but east does not meet west.

Regional differences in heart failure with preserved ejection fraction trials: when nephrology meets cardiology but east does not meet west.

Source :

English descriptors

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki